Biologics Drug Development Market - Global Outlook and Forecast 2022-2028

March 2022 | 61 pages | ID: BA07380F6437EN
Market Monitor Global

Abstracts

Biologics are defined as pharmaceutical products obtained from living cells or microorganisms.

This report contains market size and forecasts of Biologics Drug Development in Global, including the following market information:

Global Biologics Drug Development Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Biologics Drug Development market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Clinical Manufacturing Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Biologics Drug Development include Abbvie, Allergan, Boehringer Ingelheim, Charles River Laboratories, Catalent, Lonza Group, Amgen and Sanofi, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Biologics Drug Development companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Biologics Drug Development Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Biologics Drug Development Market Segment Percentages, by Type, 2021 (%)

• Clinical Manufacturing
• Formulation Development
• Bioassay Development
• Analytical Services

Global Biologics Drug Development Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Biologics Drug Development Market Segment Percentages, by Application, 2021 (%)

• In-House
• Outsource
• Pharma Excess

Global Biologics Drug Development Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Biologics Drug Development Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Biologics Drug Development revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Biologics Drug Development revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Abbvie
• Allergan
• Boehringer Ingelheim
• Charles River Laboratories
• Catalent
• Lonza Group
• Amgen
• Sanofi

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Biologics Drug Development Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Biologics Drug Development Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL BIOLOGICS DRUG DEVELOPMENT OVERALL MARKET SIZE

2.1 Global Biologics Drug Development Market Size: 2021 VS 2028
2.2 Global Biologics Drug Development Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Biologics Drug Development Players in Global Market
3.2 Top Global Biologics Drug Development Companies Ranked by Revenue
3.3 Global Biologics Drug Development Revenue by Companies
3.4 Top 3 and Top 5 Biologics Drug Development Companies in Global Market, by Revenue in 2021
3.5 Global Companies Biologics Drug Development Product Type
3.6 Tier 1, Tier 2 and Tier 3 Biologics Drug Development Players in Global Market
  3.6.1 List of Global Tier 1 Biologics Drug Development Companies
  3.6.2 List of Global Tier 2 and Tier 3 Biologics Drug Development Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Biologics Drug Development Market Size Markets, 2021 & 2028
  4.1.2 Clinical Manufacturing
  4.1.3 Formulation Development
  4.1.4 Bioassay Development
  4.1.5 Analytical Services
4.2 By Type - Global Biologics Drug Development Revenue & Forecasts
  4.2.1 By Type - Global Biologics Drug Development Revenue, 2017-2022
  4.2.2 By Type - Global Biologics Drug Development Revenue, 2023-2028
  4.2.3 By Type - Global Biologics Drug Development Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Biologics Drug Development Market Size, 2021 & 2028
  5.1.2 In-House
  5.1.3 Outsource
  5.1.4 Pharma Excess
5.2 By Application - Global Biologics Drug Development Revenue & Forecasts
  5.2.1 By Application - Global Biologics Drug Development Revenue, 2017-2022
  5.2.2 By Application - Global Biologics Drug Development Revenue, 2023-2028
  5.2.3 By Application - Global Biologics Drug Development Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Biologics Drug Development Market Size, 2021 & 2028
6.2 By Region - Global Biologics Drug Development Revenue & Forecasts
  6.2.1 By Region - Global Biologics Drug Development Revenue, 2017-2022
  6.2.2 By Region - Global Biologics Drug Development Revenue, 2023-2028
  6.2.3 By Region - Global Biologics Drug Development Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Biologics Drug Development Revenue, 2017-2028
  6.3.2 US Biologics Drug Development Market Size, 2017-2028
  6.3.3 Canada Biologics Drug Development Market Size, 2017-2028
  6.3.4 Mexico Biologics Drug Development Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Biologics Drug Development Revenue, 2017-2028
  6.4.2 Germany Biologics Drug Development Market Size, 2017-2028
  6.4.3 France Biologics Drug Development Market Size, 2017-2028
  6.4.4 U.K. Biologics Drug Development Market Size, 2017-2028
  6.4.5 Italy Biologics Drug Development Market Size, 2017-2028
  6.4.6 Russia Biologics Drug Development Market Size, 2017-2028
  6.4.7 Nordic Countries Biologics Drug Development Market Size, 2017-2028
  6.4.8 Benelux Biologics Drug Development Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Biologics Drug Development Revenue, 2017-2028
  6.5.2 China Biologics Drug Development Market Size, 2017-2028
  6.5.3 Japan Biologics Drug Development Market Size, 2017-2028
  6.5.4 South Korea Biologics Drug Development Market Size, 2017-2028
  6.5.5 Southeast Asia Biologics Drug Development Market Size, 2017-2028
  6.5.6 India Biologics Drug Development Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Biologics Drug Development Revenue, 2017-2028
  6.6.2 Brazil Biologics Drug Development Market Size, 2017-2028
  6.6.3 Argentina Biologics Drug Development Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Biologics Drug Development Revenue, 2017-2028
  6.7.2 Turkey Biologics Drug Development Market Size, 2017-2028
  6.7.3 Israel Biologics Drug Development Market Size, 2017-2028
  6.7.4 Saudi Arabia Biologics Drug Development Market Size, 2017-2028
  6.7.5 UAE Biologics Drug Development Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Abbvie
  7.1.1 Abbvie Corporate Summary
  7.1.2 Abbvie Business Overview
  7.1.3 Abbvie Biologics Drug Development Major Product Offerings
  7.1.4 Abbvie Biologics Drug Development Revenue in Global Market (2017-2022)
  7.1.5 Abbvie Key News
7.2 Allergan
  7.2.1 Allergan Corporate Summary
  7.2.2 Allergan Business Overview
  7.2.3 Allergan Biologics Drug Development Major Product Offerings
  7.2.4 Allergan Biologics Drug Development Revenue in Global Market (2017-2022)
  7.2.5 Allergan Key News
7.3 Boehringer Ingelheim
  7.3.1 Boehringer Ingelheim Corporate Summary
  7.3.2 Boehringer Ingelheim Business Overview
  7.3.3 Boehringer Ingelheim Biologics Drug Development Major Product Offerings
  7.3.4 Boehringer Ingelheim Biologics Drug Development Revenue in Global Market (2017-2022)
  7.3.5 Boehringer Ingelheim Key News
7.4 Charles River Laboratories
  7.4.1 Charles River Laboratories Corporate Summary
  7.4.2 Charles River Laboratories Business Overview
  7.4.3 Charles River Laboratories Biologics Drug Development Major Product Offerings
  7.4.4 Charles River Laboratories Biologics Drug Development Revenue in Global Market (2017-2022)
  7.4.5 Charles River Laboratories Key News
7.5 Catalent
  7.5.1 Catalent Corporate Summary
  7.5.2 Catalent Business Overview
  7.5.3 Catalent Biologics Drug Development Major Product Offerings
  7.5.4 Catalent Biologics Drug Development Revenue in Global Market (2017-2022)
  7.5.5 Catalent Key News
7.6 Lonza Group
  7.6.1 Lonza Group Corporate Summary
  7.6.2 Lonza Group Business Overview
  7.6.3 Lonza Group Biologics Drug Development Major Product Offerings
  7.6.4 Lonza Group Biologics Drug Development Revenue in Global Market (2017-2022)
  7.6.5 Lonza Group Key News
7.7 Amgen
  7.7.1 Amgen Corporate Summary
  7.7.2 Amgen Business Overview
  7.7.3 Amgen Biologics Drug Development Major Product Offerings
  7.7.4 Amgen Biologics Drug Development Revenue in Global Market (2017-2022)
  7.7.5 Amgen Key News
7.8 Sanofi
  7.8.1 Sanofi Corporate Summary
  7.8.2 Sanofi Business Overview
  7.8.3 Sanofi Biologics Drug Development Major Product Offerings
  7.8.4 Sanofi Biologics Drug Development Revenue in Global Market (2017-2022)
  7.8.5 Sanofi Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Biologics Drug Development Market Opportunities & Trends in Global Market
Table 2. Biologics Drug Development Market Drivers in Global Market
Table 3. Biologics Drug Development Market Restraints in Global Market
Table 4. Key Players of Biologics Drug Development in Global Market
Table 5. Top Biologics Drug Development Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Biologics Drug Development Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Biologics Drug Development Revenue Share by Companies, 2017-2022
Table 8. Global Companies Biologics Drug Development Product Type
Table 9. List of Global Tier 1 Biologics Drug Development Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Biologics Drug Development Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Biologics Drug Development Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Biologics Drug Development Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Biologics Drug Development Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Biologics Drug Development Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Biologics Drug Development Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Biologics Drug Development Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Biologics Drug Development Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Biologics Drug Development Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Biologics Drug Development Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Biologics Drug Development Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Biologics Drug Development Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Biologics Drug Development Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Biologics Drug Development Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Biologics Drug Development Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Biologics Drug Development Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Biologics Drug Development Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Biologics Drug Development Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Biologics Drug Development Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Biologics Drug Development Revenue, (US$, Mn), 2023-2028
Table 30. Abbvie Corporate Summary
Table 31. Abbvie Biologics Drug Development Product Offerings
Table 32. Abbvie Biologics Drug Development Revenue (US$, Mn), (2017-2022)
Table 33. Allergan Corporate Summary
Table 34. Allergan Biologics Drug Development Product Offerings
Table 35. Allergan Biologics Drug Development Revenue (US$, Mn), (2017-2022)
Table 36. Boehringer Ingelheim Corporate Summary
Table 37. Boehringer Ingelheim Biologics Drug Development Product Offerings
Table 38. Boehringer Ingelheim Biologics Drug Development Revenue (US$, Mn), (2017-2022)
Table 39. Charles River Laboratories Corporate Summary
Table 40. Charles River Laboratories Biologics Drug Development Product Offerings
Table 41. Charles River Laboratories Biologics Drug Development Revenue (US$, Mn), (2017-2022)
Table 42. Catalent Corporate Summary
Table 43. Catalent Biologics Drug Development Product Offerings
Table 44. Catalent Biologics Drug Development Revenue (US$, Mn), (2017-2022)
Table 45. Lonza Group Corporate Summary
Table 46. Lonza Group Biologics Drug Development Product Offerings
Table 47. Lonza Group Biologics Drug Development Revenue (US$, Mn), (2017-2022)
Table 48. Amgen Corporate Summary
Table 49. Amgen Biologics Drug Development Product Offerings
Table 50. Amgen Biologics Drug Development Revenue (US$, Mn), (2017-2022)
Table 51. Sanofi Corporate Summary
Table 52. Sanofi Biologics Drug Development Product Offerings
Table 53. Sanofi Biologics Drug Development Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Biologics Drug Development Segment by Type in 2021
Figure 2. Biologics Drug Development Segment by Application in 2021
Figure 3. Global Biologics Drug Development Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Biologics Drug Development Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Biologics Drug Development Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Biologics Drug Development Revenue in 2021
Figure 8. By Type - Global Biologics Drug Development Revenue Market Share, 2017-2028
Figure 9. By Application - Global Biologics Drug Development Revenue Market Share, 2017-2028
Figure 10. By Region - Global Biologics Drug Development Revenue Market Share, 2017-2028
Figure 11. By Country - North America Biologics Drug Development Revenue Market Share, 2017-2028
Figure 12. US Biologics Drug Development Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Biologics Drug Development Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Biologics Drug Development Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Biologics Drug Development Revenue Market Share, 2017-2028
Figure 16. Germany Biologics Drug Development Revenue, (US$, Mn), 2017-2028
Figure 17. France Biologics Drug Development Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Biologics Drug Development Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Biologics Drug Development Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Biologics Drug Development Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Biologics Drug Development Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Biologics Drug Development Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Biologics Drug Development Revenue Market Share, 2017-2028
Figure 24. China Biologics Drug Development Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Biologics Drug Development Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Biologics Drug Development Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Biologics Drug Development Revenue, (US$, Mn), 2017-2028
Figure 28. India Biologics Drug Development Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Biologics Drug Development Revenue Market Share, 2017-2028
Figure 30. Brazil Biologics Drug Development Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Biologics Drug Development Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Biologics Drug Development Revenue Market Share, 2017-2028
Figure 33. Turkey Biologics Drug Development Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Biologics Drug Development Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Biologics Drug Development Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Biologics Drug Development Revenue, (US$, Mn), 2017-2028
Figure 37. Abbvie Biologics Drug Development Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Allergan Biologics Drug Development Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Boehringer Ingelheim Biologics Drug Development Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Charles River Laboratories Biologics Drug Development Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Catalent Biologics Drug Development Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Lonza Group Biologics Drug Development Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Amgen Biologics Drug Development Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Sanofi Biologics Drug Development Revenue Year Over Year Growth (US$, Mn) & (2017-2022)